Funding Agency

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Small Business Innovation Research Grants (SBIR) - Phase II (R44)
Project #
5R44CA056209-03
Application #
2683518
Study Section
Special Emphasis Panel (ZRG2-SSS-4 (02))
Program Officer
Muszynski, Karen
Project Start
1992-07-01
Project End
1999-09-30
Budget Start
1998-04-15
Budget End
1999-09-30
Support Year
3
Fiscal Year
1998
Total Cost
Indirect Cost

  Institution

Name
Immunogen, Inc.
Department
Type
DUNS #
City
Cambridge
State
MA
Country
United States
Zip Code
02139

  Publications

Xie, Hongsheng; Audette, Charlene; Hoffee, Mary et al. (2004) Pharmacokinetics and biodistribution of the antitumor immunoconjugate, cantuzumab mertansine (huC242-DM1), and its two components in mice. J Pharmacol Exp Ther 308:1073-82